CD4 + CD25 high Foxp3 + T regulatory cells kill autologous CD8(+) and CD4(+) T cells using Fas/FasL- and Granzyme B- mediated pathways
|
|
- Amanda Wilcox
- 6 years ago
- Views:
Transcription
1 CD4 + CD25 high Foxp3 + T regulatory cells kill autologous CD8(+) and CD4(+) T cells using Fas/FasL- and Granzyme B- mediated pathways Laura Strauss, Christoph Bergmann, Theresa L. Whiteside University of Pittsburgh Cancer Institute and Departments of Pathology, Immunology and Otolaryngology, University of Pittsburgh School of Medicine, Pittsburgh, PA FoxP3 +
2 Objectives of our study were: To define mechanisms employed by Treg to mediate suppression of proliferating T responder cells (RC) We considered 3 possible mechanisms: 1. Cytokine- mediated death. 2. Death receptor-mediated apoptosis. 3. Cytolysis mediated by granzymes/perforin.
3 Methods for studies of Treg Isolate CD4+CD25 high and CD4+CD25 neg or CD8+CD25 neg T cells from PBMC of NC or patients with cancer bv single-cell sorting (FACS) Multicolor flow cytometry: phenotype Suppressor function: CFSE-labeled RC (+ OKT3+ IL-2) + 5-day co-culture Unlabeled S Suppression of RC proliferation Laser + 7-AAD FLOCA (Flow cytometry-based cytotoxicity assay)
4 We have shown before that CD8 + T effector cells in the circulation of patients with HNSCC (but not NC) are highly sensitive to apoptosis 4,5 Apoptosis in fresh T cell subsets from HNSCC patient and NC fresh PBMC NC Annex V gated on CD3 + CD8 + CD25 - gated on CD3 + CD4 + CD25 -.3%.2% CD8 CD4 fresh PBMC HNSCC 72% 5.1% CD8 CD4 4 Reichert et al., 2 5 Hoffmann et al., 22
5 Treg mediate suppression of autologous CD4 + or CD8 + RC proliferation via direct cell-cell contact 6 7 % Treg in PBMC Gated on CD4 + CD25 high T cells CD4 + CD25 high + CD4 + CD25 - or CD8 + CD25 - co-cultures 9 p % CD25 high cells P.1 % Suppression S:RC ratio:1:2 1 1 NC (n=15) HNSCC (n=35) non-tr n = 5 TR 6 Strauss et al., 27, Clinical Cancer Res, 1:13 (15):4352
6 Human CD4 + CD25 high Treg suppress proliferation and induce apoptosis in autologous CD8 + responder cells 5-day co-cultures in the presence of 15 IU/mL IL-2 + OKT3 Responder cells alone (RC) (CD8 + CD25 neg ) CD8 + (RC) cells (RC) cells + CD4 + CD25 high (S) S/RC=1:1 Events % HNSCC 6 7-AAD.3% 99.7% CD8 + (RC) cells 56% 24% CFSE 12 CD8 + 2
7 Human CD4 + CD25 high Treg suppress proliferation but do not mediate apoptosis in autologous CD4 + responder cells 5-day co-cultures in the presence of 15 IU/mL IL-2 + OKT3 Responder cells alone (RC) (CD4 + CD25 neg ) CD4 + (RC) cells (RC) cells + CD4 + CD25 high (S) S/RC=1:1 Events % HNSCC 7-AAD 1.2% 98.8% CD4 + (RC) cells.2% 7-AAD Treg Tr cells 82% 77.4% 18.8% 15% CFSE 99.8% CD4 + 8% 3% CD4 +
8 Expression of Fas and FasL on CD4 + CD25 T cells in NC or HNSCC patients CD25 high % positive cells FRESH PBMC p.1 Fas NC (n=15) HNSCC (n=35) p.3 FasL Fas FasL Normal HNSCC Control gated on CD4 + CD25 high T cells 43% 95% 5.5% 92% FasL CD4
9 Treg can kill autologous CD8 + CD25 - RC but not CD4 + CD25 - RC via the Fas/FasL pathway + CFSE-labeled CD8 + RC CD4 + CD25 high Treg (FasL+) + CFSE-labeled CD4 + RC 56% 92% 2 92% 24% Events 68% Events 2 12% 7-AAD + anti-fasl- Ab AAD + anti-fasl- Ab % 1%.3% Events 62% 18% 72% Events 97% 99% 99.7 % CD CFSE CD CFSE 15 IU/mL IL-2 1 IU/mL IL-2 Results of cell death obtained in FLOCA
10 Expression of Granzymes and Perforin in fresh and activated peripheral T-cell T subsets A. MFI±SD Gated on CD4 + CD25 high in fresh PBMC 16 NC n=15 HNSCC n=25 14 * *p * +OKT3, IL-2 (15 IU/mL) MFI±SD Activated CD4 + CD25 high * NC n=15 HNSCC n=25 *p.3 * Granzyme B Granzyme A Perforin Granzyme B Granzyme A Perforin B. Gated on CD4 + CD25 - in fresh PBMC 16 NC n=15 14 HNSCC n= Activated CD4 + CD25 high NC n=15 HNSCC n= MFI±SD 1 8 MFI±SD Granzyme B Granzyme A Perforin Granzyme B Granzyme A Perforin
11 Expression of cytotoxins is regulated by IL-2 2 in the presence of the partner T cell (15 IU IL-2/mL) (1 IU IL-2/mL) CD4 + CD25 neg after co-incubation with Treg cells 1S:1 (RC) Granzyme B-PE 98% 97% 88% Granzyme A-PE Perforin-FITC Granzyme B-PE 25% 1% 15% Granzyme A-PE Perforin-FITC R CD4 + CD25 high after co-incubation with CD4+ RC cells 1S:1 (RC) Granzyme B-PE 3% 4% 7% Granzyme A-PE Perforin-FITC Granzyme B-PE CD4 99% PerCP Granzyme A-PE 92% 75% Perforin-FITC S CD4 5-day co-cultures of Treg and autologous RC
12 Treg suppress CD4+ RC at low and high dose of IL-2, but can kill RC only at high IL-2 2 concentrations S/RC=1:1 (15 IU IL-2/mL) 96% HNSCC CD4 + (RC) cells Treg Tr cells 77.4% 82% % 99.8% 15% 18.8% 8% 3% 7-AAD Events 98% HNSCC CD4 + (RC) cells Treg (1 IU IL-2/mL) 78% % 1 CFSE CD4 At low IL-2 doses, Treg induce suppression of RC proliferation and then undergo apoptosis. This type of suppression does not involve death of RC.
13 Conclusion 1 Mechanisms responsible for RC death and Treg survival in these co-cultures are IL-2 dependent
14 Treg- mediated killing of CD4 + RC is GranzymeB- dependent, but Perforin-independent independent CD4 + (RC) cells Treg 1 IU/mL IL-2 98%.5% Data.22 64%.4% % 99.6% Events 7-AAD Granzyme B-PE 97% + sirna GrB 6% CD4 + (RC) cells Treg.2%.3% CFSE 99.8% CD4 CD-4 Granzyme B-PE 12% 99.7%
15 CD4 + RC- mediated killing of Treg is GranzymeB and Perforin-dependent CD4 + (RC) cells Treg 15 IU/mL IL-2 82% Data.22.5%.4% 64% % 35.5% Events 7-AAD Perforin-FITC 97% 98% CD4 + (RC) cells +ConcanamycinA Treg % 93% CFSE Perforin-FITC 7% CD-4
16 Conclusion 2 The GranzymeB-mediated reciprocal killing mediated by RC or Treg is IL-2-dependent
17 Expression of proteins that protect from apoptosis is regulated by IL-2 Bcl-2 (MFI±SD) Fresh PBMC * NC n=15 HNSCC n=35 * p.1 PI-9 expression in Treg and RC after co-culture + IL-2 PI-9 NC AD NED 1 IU/mL IL-2: MFI ± SD CD4 + CD25 high 83 ± 5* 115 ± 1* 15* ± 12 CD4 + CD25-25 ± ± 1 32 ± 2.5 CD8 + CD25-12 ± ± ± 5.8 *p.1 for differences between Treg and RC 15 IU/mL IL-2: CD4 + CD25 high 22 ± 6.7* 18 ± 4.58* 18 ± 2.5* CD4 + CD25-85 ± ± ± 1 Foxp3 high Foxp3 interm. Foxp3 low CD8 + CD25-95 ± ± 8 54 ± 12 *p.3 for differences between Treg and RC At low IL-2 concentrations, Treg co-cultured with RC do not up-regulate PI-9 and are sensitive to GrB-mediated apoptosis.
18 Conclusions Treg can suppress RC via three different mechanisms Tr1 largely use IL-1 and TGFβ1 to suppress RC proliferation (a contact independent process) CD8+RC expansion is suppressed by the Fas/FasLmediated apoptosis CD4+RC proliferation is suppressed via a contactdependent GrB/perforin pathway which is regulated by the IL-2 concentration in the microenvironment Resistance or sensitivity to death of Treg vs. RC is dependent on IL-2-mediated T cell activation
Cytotoxicity assays. Rory D. de Vries, PhD 1. Viroscience lab, Erasmus MC, Rotterdam, the Netherlands
Cytotoxicity assays Rory D. de Vries, PhD 1 1 Viroscience lab, Erasmus MC, Rotterdam, the Netherlands Anti-influenza immunity Humoral / CD4+ / CD8+ / NK? Function of CTL Elimination of virus-infected cells?
More informationAdaptive (acquired) immunity. Professor Peter Delves University College London
Adaptive (acquired) immunity Professor Peter Delves University College London p.delves@ucl.ac.uk Haematopoiesis Haematopoiesis Lymphocytes = adaptive response Recognition of pathogens by adaptive cells,
More informationFluorochrome Panel 1 Panel 2 Panel 3 Panel 4 Panel 5 CTLA-4 CTLA-4 CD15 CD3 FITC. Bio) PD-1 (MIH4, BD) ICOS (C398.4A, Biolegend) PD-L1 (MIH1, BD)
Additional file : Table S. Antibodies used for panel stain to identify peripheral immune cell subsets. Panel : PD- signaling; Panel : CD + T cells, CD + T cells, B cells; Panel : Tregs; Panel :, -T, cdc,
More informationNaive, memory and regulatory T lymphocytes populations analysis
Naive, memory and regulatory T lymphocytes populations analysis Jaen Olivier, PhD ojaen@beckmancoulter.com Cellular Analysis application specialist Beckman Coulter France Introduction Flow cytometric analysis
More informationCancer Biometrics: Results of the 2003 isbtc Workshop. Theresa L. Whiteside, Ph.D., ABMLI University of Pittsburgh Cancer Institute
Cancer Biometrics: Results of the 2003 isbtc Workshop Theresa L. Whiteside, Ph.D., ABMLI University of Pittsburgh Cancer Institute The workshop objective The objective was to consider state-of-theart approaches
More informationSupplementary Data. Treg phenotype
Supplementary Data Additional Experiment An additional experiment was performed using cryopreserved peripheral blood mononuclear cells (PBMC) derived from five renal cell carcinoma (RCC) patients [see
More informationCover Page. The handle holds various files of this Leiden University dissertation.
Cover Page The handle http://hdl.handle.net/1887/23854 holds various files of this Leiden University dissertation. Author: Marel, Sander van der Title: Gene and cell therapy based treatment strategies
More informationSUPPLEMENT Supplementary Figure 1: (A) (B)
SUPPLEMENT Supplementary Figure 1: CD4 + naïve effector T cells (CD4 effector) were labeled with CFSE, stimulated with α-cd2/cd3/cd28 coated beads (at 2 beads/cell) and cultured alone or cocultured with
More informationTumor-Derived Microvesicles Induce, Expand and Up- Regulate Biological Activities of Human Regulatory T Cells (Treg)
Tumor-Derived Microvesicles Induce, Expand and Up- Regulate Biological Activities of Human Regulatory T Cells (Treg) Marta Szajnik 2", Malgorzata Czystowska 2, Miroslaw J. Szczepanski 2", Magis Mandapathil
More informationAlessandra Franco, M.D., Ph.D. UCSD School of Medicine Department of Pediatrics Division of Allergy, Immunology and Rheumatology
Natural regulatory T cells recognize the heavy constant region (Fc) of immunoglobulins: a novel mechanism for IVIG immunotherapy in Pediatric Immune-mediated diseases Alessandra Franco, M.D., Ph.D. UCSD
More informationGlioma cancer stem cells mediate immune suppression that can be reversed with STAT3 blockade
Glioma cancer stem cells mediate immune suppression that can be reversed with STAT3 blockade Jun Wei Department of Neurosurgery October 23, 2009 Immune suppression in Malignant Glioma Patients Mechanisms
More informationSupplementary Table e-1. Flow cytometry reagents and staining combinations
Supplementary data Supplementary Table e-1. Flow cytometry reagents and staining combinations Reagents Antibody Fluorochrome Clone Source conjugation CD3 FITC UCHT1 BD Biosciences CD3 PerCP-Cy5.5 SK7 Biolegend
More informationScott Abrams, Ph.D. Professor of Oncology, x4375 Kuby Immunology SEVENTH EDITION
Scott Abrams, Ph.D. Professor of Oncology, x4375 scott.abrams@roswellpark.org Kuby Immunology SEVENTH EDITION CHAPTER 13 Effector Responses: Cell- and Antibody-Mediated Immunity Copyright 2013 by W. H.
More informationCELLULAR AND MOLECULAR REQUIREMENTS FOR REJECTION OF B16 MELANOMA IN THE SETTING OF REGULATORY T CELL DEPLETION AND HOMEOSTATIC PROLIFERATION
CELLULAR AND MOLECULAR REQUIREMENTS FOR REJECTION OF B16 MELANOMA IN THE SETTING OF REGULATORY T CELL DEPLETION AND HOMEOSTATIC PROLIFERATION Justin Kline 1, Long Zhang 1, and Thomas F. Gajewski 1,2 Departments
More informationOptimizing Intracellular Flow Cytometry:
Optimizing Intracellular Flow Cytometry: Simultaneous Detection of Cytokines and Transcription Factors Presented by Jurg Rohrer, PhD, BD Biosciences 23-10780-00 Outline Introduction Cytokines Transcription
More informationIn vitro human regulatory T cell expansion
- 1 - Human CD4 + CD25 + regulatory T cell isolation, Workflow in vitro expansion and analysis In vitro human regulatory T cell expansion Introduction Regulatory T (Treg) cells are a subpopulation of T
More informationTumor Microenvironment and Immune Suppression
Tumor Microenvironment and Immune Suppression Hassane M. Zarour,, MD Department of Medicine, Division of Hematology-Oncology, University of Pittsburgh Cancer Institute Hallmarks of Cancer: The Next Generation
More informationIn vitro human regulatory T cell expansion
- 1 - Human CD4 + CD25 + CD127 dim/- regulatory T cell Workflow isolation, in vitro expansion and analysis In vitro human regulatory T cell expansion Introduction Regulatory T (Treg) cells are a subpopulation
More informationChildren's Hospital of Pittsburgh Annual Progress Report: 2011 Formula Grant
Children's Hospital of Pittsburgh Annual Progress Report: 2011 Formula Grant Reporting Period July 1, 2012 June 30, 2013 Formula Grant Overview The Children's Hospital of Pittsburgh received $228,401 in
More informationBioassays for Quality Control of Cell & Gene Therapy Products
Bioassays for Quality Control of Cell & Gene Therapy Products Erik Rutjens, Cell & Gene Therapy, Novartis Pharma AG CASSS Bioassays, Silver Spring, March2015 CTL019 Introduction CARTs = Chimeric Antigen
More informationT cell and Cell-mediated immunity
T cell and Cell-mediated immunity Lu Linrong ( 鲁林荣 ) PhD Laboratory of Immune Regulation Institute of Immunology Zhejiang University, it School of Medicine i Medical Research Building B815-819 Email: Lu.Linrong@gmail.com
More informationSelective Survival of Naturally Occurring Human CD4 CD25 Foxp3 Regulatory T Cells Cultured with Rapamycin 1
Selective Survival of Naturally Occurring Human CD4 CD25 Foxp3 Regulatory T Cells Cultured with Rapamycin 1 Laura Strauss, 2 * Theresa L. Whiteside, Ashley Knights,* Christoph Bergmann, Alexander Knuth,*
More informationCD25-PE (BD Biosciences) and labeled with anti-pe-microbeads (Miltenyi Biotec) for depletion of CD25 +
Supplements Supplemental Materials and Methods Depletion of CD25 + T-cells from PBMC. Fresh or HD precultured PBMC were stained with the conjugate CD25-PE (BD Biosciences) and labeled with anti-pe-microbeads
More informationBD Flow Cytometry Reagents Multicolor Panels Designed for Optimal Resolution with the BD LSRFortessa X-20 Cell Analyzer
Multicolor Panels Designed for Optimal Resolution with the BD LSRFortessa X-2 Cell Analyzer Proper multicolor panel design takes into account fluorochrome brightness, antigen density, co-expression, and
More informationHuman and mouse T cell regulation mediated by soluble CD52 interaction with Siglec-10. Esther Bandala-Sanchez, Yuxia Zhang, Simone Reinwald,
Human and mouse T cell regulation mediated by soluble CD52 interaction with Siglec-1 Esther Bandala-Sanchez, Yuxia Zhang, Simone Reinwald, James A. Dromey, Bo Han Lee, Junyan Qian, Ralph M Böhmer and Leonard
More informationof whole cell cultures in U-bottomed wells of a 96-well plate are shown. 2
Supplementary online material Supplementary figure legends Supplementary Figure 1 Exposure to T reg cells causes loss of T resp cells in co-cultures. T resp cells were stimulated with CD3+CD28 alone or
More informationAltered regulatory T cell homeostasis in patients with CD4 + lymphopenia following allogeneic hematopoietic stem cell transplantation
Altered regulatory T cell homeostasis in patients with CD4 + lymphopenia following allogeneic hematopoietic stem cell transplantation Ken-ichi Matsuoka,, Robert J. Soiffer, Jerome Ritz J Clin Invest. 2010;120(5):1479-1493.
More information% of Cells A B C. Proliferation Index. T cell count (10 6 ) Division Index. % of Max CFSE. %Ki67+ cells. Supplementary Figure 1.
A B C T cell count (1 6 ) 3. 2. 1.. * % of Max CFSE ormoxia ypoxia o Stim. Proliferation Index 2.5 2. 1.5 1. * Division Index 2. 1.5 1..5. D E %Ki67+ cells 1 8 6 4 2 % of Cells 8 ormoxia 6 ypoxia 4 2 *
More informationDetailed step-by-step operating procedures for NK cell and CTL degranulation assays
Supplemental methods Detailed step-by-step operating procedures for NK cell and CTL degranulation assays Materials PBMC isolated from patients, relatives and healthy donors as control K562 cells (ATCC,
More informationCellular Immune response. Jianzhong Chen, Ph.D Institute of immunology, ZJU
Cellular Immune response Jianzhong Chen, Ph.D Institute of immunology, ZJU Concept of adaptive immune response T cell-mediated adaptive immune response I. Concept of immune response A collective and coordinated
More informationJournal of Immunological Methods
Journal of Immunological Methods 346 (2009) 55 63 Contents lists available at ScienceDirect Journal of Immunological Methods journal homepage: www.elsevier.com/locate/jim Research paper Isolation of functional
More informationT cell and Cell-mediated immunity
T cell and Cell-mediated immunity ( 第十章 第十二章第十二章 ) Lu Linrong ( 鲁林荣 ) PhD Laboratory of Immune Regulation Institute of Immunology Zhejiang University, School of Medicine Medical Research Building B815-819
More informationankylosing spondylitis Department of Clinical Immunology, Xijing Hospital, The Fourth Military
Functional defects in CD4 + CD25 high FoxP3 + regulatory cells in ankylosing spondylitis Huifang Guo 1, 2, 3, Ming Zheng 1, 2, 3, Kui Zhang 1, 3, Fengfan Yang 1, 3, Xin Zhang 1, 3, Qing Han 1, 3, Zhi-Nan
More informationOptimizing Intracellular Flow Cytometry:
Optimizing Intracellular Flow Cytometry: Simultaneous Detection of Cytokines and Transcription Factors An encore presentation by Jurg Rohrer, PhD, BD Biosciences 10.26.10 Outline Introduction Cytokines
More informationSupplementary Figure 1. Example of gating strategy
Supplementary Figure 1. Example of gating strategy Legend Supplementary Figure 1: First, gating is performed to include only single cells (singlets) (A) and CD3+ cells (B). After gating on the lymphocyte
More informationSupplementary Figure 1. Efficiency of Mll4 deletion and its effect on T cell populations in the periphery. Nature Immunology: doi: /ni.
Supplementary Figure 1 Efficiency of Mll4 deletion and its effect on T cell populations in the periphery. Expression of Mll4 floxed alleles (16-19) in naive CD4 + T cells isolated from lymph nodes and
More informationNK cell flow cytometric assay In vivo DC viability and migration assay
NK cell flow cytometric assay 6 NK cells were purified, by negative selection with the NK Cell Isolation Kit (Miltenyi iotec), from spleen and lymph nodes of 6 RAG1KO mice, injected the day before with
More informationSupplemental Table I.
Supplemental Table I Male / Mean ± SEM n Mean ± SEM n Body weight, g 29.2±0.4 17 29.7±0.5 17 Total cholesterol, mg/dl 534.0±30.8 17 561.6±26.1 17 HDL-cholesterol, mg/dl 9.6±0.8 17 10.1±0.7 17 Triglycerides,
More informationSupplementalgfigureg1gSchematicgdiagramgofgtumor1modellingg
SChinjectionh F:LuchLCLsh IVhinjectionh T:cellsh Monitorhforhtumorh growthhandhxeno: reactivehgvhd GVLgexperimentg kcbgvsgpbgt1cellse Xeno1reactiveg experimentg kcbgvsgpbgt1cellse IVhinjectionh 5xh,N^6
More informationmtor and MEK1/2 inhibition differentially modulate tumor growth and the immune microenvironment in syngeneic models of oral cavity cancer
Washington University School of Medicine Digital Commons@Becker Open Access Publications 2015 mtor and MEK1/2 inhibition differentially modulate tumor growth and the immune microenvironment in syngeneic
More informationPractical Solution: presentation to cytotoxic T cells. How dendritic cells present antigen. How dendritic cells present antigen
Christian Kurts Institutes of Molecular Medicine and Experimental Immunology University of Bonn, Germany - presentation and (CTL) activation - I presentation and CD4 + T cell (Th cell) activation Different
More informationSupplementary Figure 1. mrna expression of chitinase and chitinase-like protein in splenic immune cells. Each splenic immune cell population was
Supplementary Figure 1. mrna expression of chitinase and chitinase-like protein in splenic immune cells. Each splenic immune cell population was sorted by FACS. Surface markers for sorting were CD11c +
More informationSPONTANEOUS APOPTOSIS OF TUMOR-SPECIFIC TETRAMER 1 CD8 1 T LYMPHOCYTES IN THE PERIPHERAL CIRCULATION OF PATIENTS WITH HEAD AND NECK CANCER
ORIGINAL ARTICLE SPONTANEOUS APOPTOSIS OF TUMOR-SPECIFIC TETRAMER 1 CD8 1 T LYMPHOCYTES IN THE PERIPHERAL CIRCULATION OF PATIENTS WITH HEAD AND NECK CANCER Andreas E. Albers, MD, PhD, 1,2 Carsten Schaefer,
More informationA step-by-step approach to build and analyze a multicolor panel
Analyze A step-by-step approach to build and analyze a multicolor panel For Research Use Only. Not for use in diagnostic or therapeutic procedures. Alexa Fluor is a registered trademark of Life Technologies
More informationRegulatory T cell phenotype and function 4 years after GAD alum treatment in children with type 1 diabetes
Regulatory T cell phenotype and function 4 years after GAD alum treatment in children with type 1 diabetes Mikael Pihl, Linda Åkerman, Stina Axelsson, Mikael Chéramy, Maria Hjorth, R. Mallone, Johnny Ludvigsson
More informationState of the Art 3: Immunotherapy and Modulators of Apoptosis
State of the Art 3: Immunotherapy and Modulators of Apoptosis James Finke, PhD - Cleveland Clinic, Immunology Crystal Mackall, MD - NCI, Pediatric Oncology James Mier, MD - BIDMC, Medical Oncology Craig
More informationImmune response and correlates of protection against typhoid
Immune response and correlates of protection against typhoid Marcelo B. Sztein, M.D. Immunology Group Center for Vaccine Development University of Maryland Correlates of enteric vaccine-induced protection
More informationSupplementary Figure 1. IL-12 serum levels and frequency of subsets in FL patients. (A) IL-12
1 Supplementary Data Figure legends Supplementary Figure 1. IL-12 serum levels and frequency of subsets in FL patients. (A) IL-12 serum levels measured by multiplex ELISA (Luminex) in FL patients before
More informationManuscript: OX40 signaling is involved in the autoactivation of CD4 + CD28 - T cells and contributes to pathogenesis of autoimmune arthritis
Manuscript: OX40 signaling is involved in the autoactivation of CD4 + CD28 - T cells and contributes to pathogenesis of autoimmune arthritis Vincent Laufer Rheumatology JC October 17 Disclosures NIH 2
More informationSupplementary Figure Legends. group) and analyzed for Siglec-G expression utilizing a monoclonal antibody to Siglec-G (clone SH2.1).
Supplementary Figure Legends Supplemental Figure : Naïve T cells express Siglec-G. Splenocytes were isolated from WT B or Siglec-G -/- animals that have not been transplanted (n= per group) and analyzed
More informationTITLE: Fusions of Breast Carcinoma and Dendritic Cells as a Vaccine for the Treatment of Metatastic Breast Cancer
AD Award Number: DAMD17-03-1-0487 TITLE: Fusions of Breast Carcinoma and Dendritic Cells as a Vaccine for the Treatment of Metatastic Breast Cancer PRINCIPAL INVESTIGATOR: Donald Kufe, M.D. CONTRACTING
More informationSupplementary Figure 1. Double-staining immunofluorescence analysis of invasive colon and breast cancers. Specimens from invasive ductal breast
Supplementary Figure 1. Double-staining immunofluorescence analysis of invasive colon and breast cancers. Specimens from invasive ductal breast carcinoma (a) and colon adenocarcinoma (b) were staining
More informationEffector mechanisms of cell-mediated immunity: Properties of effector, memory and regulatory T cells
ICI Basic Immunology course Effector mechanisms of cell-mediated immunity: Properties of effector, memory and regulatory T cells Abul K. Abbas, MD UCSF Stages in the development of T cell responses: induction
More informationTherapeutic Immunization with Autologous DC Pulsed with Autologous Inactivated HIV-1 Infected Apoptotic Cells
Therapeutic Immunization with Autologous DC Pulsed with Autologous Inactivated HIV-1 Infected Apoptotic Cells Sharon A. Riddler, MD, MPH University of Pittsburgh May 2008 Slide 1 HIV and DC Vaccines During
More informationNKTR-255: Accessing The Immunotherapeutic Potential Of IL-15 for NK Cell Therapies
NKTR-255: Accessing The Immunotherapeutic Potential Of IL-15 for NK Cell Therapies Saul Kivimäe Senior Scientist, Research Biology Nektar Therapeutics NK Cell-Based Cancer Immunotherapy, September 26-27,
More informationRapid antigen-specific T cell enrichment (Rapid ARTE)
Direct ex vivo characterization of human antigen-specific CD154+CD4+ T cell Rapid antigen-specific T cell enrichment (Rapid ARTE) Introduction Workflow Antigen (ag)-specific T cells play a central role
More informationUmbilical Cord Blood-Derived T Regulatory Cells
Umbilical Cord Blood-Derived T Regulatory Cells David H. McKenna, M.D. PACT Workshop - University of Pittsburgh May 5, 2008 Slide 1 Outline Overview of T regulatory (T R ) cells Potential for clinical
More informationNew insights into CD8+ T cell function and regulation. Pam Ohashi Princess Margaret Cancer Centre
New insights into CD8+ T cell function and regulation Pam Ohashi Princess Margaret Cancer Centre New insights into CD8+ T cell function and regulation Pam Ohashi Princess Margaret Cancer Centre No Disclosures
More informationImmunotherapy on the Horizon: Adoptive Cell Therapy
Immunotherapy on the Horizon: Adoptive Cell Therapy Joseph I. Clark, MD, FACP Professor of Medicine Loyola University Chicago Stritch School of Medicine Maywood, IL June 23, 2016 Conflicts of Interest
More informationTolerance 2. Regulatory T cells; why tolerance fails. FOCiS. Lecture outline. Regulatory T cells. Regulatory T cells: functions and clinical relevance
1 Tolerance 2. Regulatory T cells; why tolerance fails Abul K. Abbas UCSF FOCiS 2 Lecture outline Regulatory T cells: functions and clinical relevance Pathogenesis of autoimmunity: why selftolerance fails
More informationFrom Bench to Bedside Regulatory T Cells: Can We Make the Police Work for Us?
From Bench to Bedside Regulatory T Cells: Can We Make the Police Work for Us? Sang Mo Kang, MD Qizhi Tang, PhD UCSF Division of Transplantation UCSF Transplant Conference 2012 The Reality of Immunosuppression
More informationWhat to Measure, How to Measure It
Dale and Betty Bumpers Vaccine Research Center National Institute of Allergy and Infectious Diseases National Institutes of Health Monitoring Memory T-cells: What to Measure, How to Measure It Pratip K.
More informationResearch Article Tag7 (PGLYRP1) Can Induce an Emergence of the CD3+CD4+CD25+CD127+ Cells with Antitumor Activity
Journal of Immunology Research, Article ID 4501273, 9 pages https://doi.org/10.1155/2018/4501273 Research Article Tag7 (PGLYRP1) Can Induce an Emergence of the CD3+CD4++CD127+ Cells with Antitumor Activity
More informationChemotherapy enhances tumor cell susceptibility to CTL-mediated killing during cancer immunotherapy in mice
Chemotherapy enhances tumor cell susceptibility to CTL-mediated killing during cancer immunotherapy in mice Rupal Ramakrishnan,, Esteban Celis, Dmitry I. Gabrilovich J Clin Invest. 2010;120(4):1111-1124.
More informationObjectives. Abbas Chapter 11: Immunological Tolerance. Question 1. Question 2. Question 3. Definitions
Objectives Abbas Chapter 11: Immunological Tolerance Christina Ciaccio, MD Children s Mercy Hospitals and Clinics February 1, 2010 To introduce the concept of immunologic tolerance To understand what factors
More informationSupplemental Materials
Supplemental Materials Programmed death one homolog maintains the pool size of regulatory T cells by promoting their differentiation and stability Qi Wang 1, Jianwei He 1, Dallas B. Flies 2, Liqun Luo
More informationx Lymphocyte count /µl CD8+ count/µl 800 Calculated
% Lymphocyte in CBC A. 50 40 30 20 10 Lymphocyte count /µl B. x10 3 2.5 1.5 C. 50 D. 1000 % CD3+CD8+ Cells 40 30 20 Calculated CD8+ count/µl 800 600 400 200 10 0 #61 #63 #64 #65 #68 #71 #72 #75 Figure
More informationApplication Information Bulletin: Human NK Cells Phenotypic characterizing of human Natural Killer (NK) cell populations in peripheral blood
Application Information Bulletin: Human NK Cells Phenotypic characterizing of human Natural Killer (NK) cell populations in peripheral blood Christopher A Fraker, Ph.D., University of Miami - Miami, Florida
More information5/1/13. The proportion of thymus that produces T cells decreases with age. The cellular organization of the thymus
T cell precursors migrate from the bone marrow via the blood to the thymus to mature 1 2 The cellular organization of the thymus The proportion of thymus that produces T cells decreases with age 3 4 1
More informationOptimizing Intracellular Flow Cytometry
Optimizing Intracellular Flow Cytometry Detection of Cytokines, Transcription Factors, and Phosphoprotein by Flow Cytometry Presented by Erika O Donnell, PhD, BD Biosciences 23-14876-00 Outline Basic principles
More informationGeneral Overview of Immunology. Kimberly S. Schluns, Ph.D. Associate Professor Department of Immunology UT MD Anderson Cancer Center
General Overview of Immunology Kimberly S. Schluns, Ph.D. Associate Professor Department of Immunology UT MD Anderson Cancer Center Objectives Describe differences between innate and adaptive immune responses
More informationT Cell Receptor & T Cell Development
T Cell Receptor & T Cell Development Questions for the next 2 lectures: How do you generate a diverse T cell population with functional TCR rearrangements? How do you generate a T cell population that
More informationSUPPLEMENTARY INFORMATION
Complete but curtailed T-cell response to very-low-affinity antigen Dietmar Zehn, Sarah Y. Lee & Michael J. Bevan Supp. Fig. 1: TCR chain usage among endogenous K b /Ova reactive T cells. C57BL/6 mice
More informationSupplementary Information:
Supplementary Information: Follicular regulatory T cells with Bcl6 expression suppress germinal center reactions by Yeonseok Chung, Shinya Tanaka, Fuliang Chu, Roza Nurieva, Gustavo J. Martinez, Seema
More informationTolerance 2. Regulatory T cells; why tolerance fails. Abul K. Abbas UCSF. FOCiS
1 Tolerance 2. Regulatory T cells; why tolerance fails Abul K. Abbas UCSF FOCiS 2 Lecture outline Regulatory T cells: functions and clinical relevance Pathogenesis of autoimmunity: why selftolerance fails
More informationCommercially available HLA Class II tetramers (Beckman Coulter) conjugated to
Class II tetramer staining Commercially available HLA Class II tetramers (Beckman Coulter) conjugated to PE were combined with dominant HIV epitopes (DRB1*0101-DRFYKTLRAEQASQEV, DRB1*0301- PEKEVLVWKFDSRLAFHH,
More informationCo-Stimulation through 4-1BB/CD137 Improves the Expansion and Function of CD8 + Melanoma Tumor- Infiltrating Lymphocytes for Adoptive T-Cell Therapy
Co-Stimulation through 4-1BB/CD137 Improves the Expansion and Function of CD8 + Melanoma Tumor- Infiltrating Lymphocytes for Adoptive T-Cell Therapy Jessica Ann Chacon 1,2, Richard C. Wu 1,2, Pariya Sukhumalchandra
More informationCentral tolerance. Mechanisms of Immune Tolerance. Regulation of the T cell response
Immunoregulation: A balance between activation and suppression that achieves an efficient immune response without damaging the host. Mechanisms of Immune Tolerance ACTIVATION (immunity) SUPPRESSION (tolerance)
More informationMechanisms of Immune Tolerance
Immunoregulation: A balance between activation and suppression that achieves an efficient immune response without damaging the host. ACTIVATION (immunity) SUPPRESSION (tolerance) Autoimmunity Immunodeficiency
More informationImmunological alterations in mice irradiated with low doses
Immunological alterations in mice irradiated with low doses "Frédéric Joliot-Curie" National Research Institute for Radiobiology and Radiohygiene, Budapest, Hungary The structure of the immune system INNATE
More informationEx Vivo Rapamycin Generates Apoptosis-Resistant Donor Th2 Cells That Persist In Vivo and Prevent Hemopoietic Stem Cell Graft Rejection
This information is current as of October 21, 218. References Subscription Permissions Email Alerts Ex Vivo Rapamycin Generates Apoptosis-Resistant Donor Th2 Cells That Persist In Vivo and Prevent Hemopoietic
More informationBlocking antibodies and peptides. Rat anti-mouse PD-1 (29F.1A12, rat IgG2a, k), PD-
Supplementary Methods Blocking antibodies and peptides. Rat anti-mouse PD-1 (29F.1A12, rat IgG2a, k), PD- L1 (10F.9G2, rat IgG2b, k), and PD-L2 (3.2, mouse IgG1) have been described (24). Anti-CTLA-4 (clone
More informationMultifunctional Regulatory T Cells from Human Umbilical Cord Blood and the Role of Tumor Necrosis Factor in Immune Homeostasis
Loyola University Chicago Loyola ecommons Master's Theses Theses and Dissertations 2017 Multifunctional Regulatory T Cells from Human Umbilical Cord Blood and the Role of Tumor Necrosis Factor in Immune
More informationPaucity of CD4+ Natural Killer T (NKT) Lymphocytes in Sooty Mangabeys is Associated with Lack of NKT Cell Depletion After SIV Infection
Paucity of CD4+ Natural Killer T (NKT) Lymphocytes in Sooty Mangabeys is Associated with Lack of NKT Cell Depletion After SIV Infection The Harvard community has made this article openly available. Please
More information7-AAD/CFSE Cell-Mediated Cytotoxicity Assay Kit
7-AAD/CFSE Cell-Mediated Cytotoxicity Assay Kit Item No. 600120 www.caymanchem.com Customer Service 800.364.9897 Technical Support 888.526.5351 1180 E. Ellsworth Rd Ann Arbor, MI USA TABLE OF CONTENTS
More informationCD14 + S100A9 + Monocytic Myeloid-Derived Suppressor Cells and Their Clinical Relevance in Non-Small Cell Lung Cancer
CD14 + S1A9 + Monocytic Myeloid-Derived Suppressor Cells and Their Clinical Relevance in Non-Small Cell Lung Cancer Po-Hao, Feng M.D., Kang-Yun, Lee, M.D. Ph.D., Ya-Ling Chang, Yao-Fei Chan, Lu- Wei, Kuo,Ting-Yu
More informationNovel RCC Targets from Immuno-Oncology and Antibody-Drug Conjugates
Novel RCC Targets from Immuno-Oncology and Antibody-Drug Conjugates Christopher Turner, MD Vice President, Clinical Science 04 November 2016 Uveal Melanoma Celldex Pipeline CANDIDATE INDICATION Preclinical
More informationFrom the Diagnostic Immunology Laboratories
From the Diagnostic ISSUE 10 SPRING 2013 PAGE 1 Spring Meeting Please stop by and say hello in April at this year s American Society of Pediatric Hematology/Oncology (ASPHO) Annual Meeting in Miami, Florida.
More informationB6/COLODR/SPL/11C/83/LAP/#2.006 B6/COLODR/SPL/11C/86/LAP/#2.016 CD11C B6/COLODR/SPL/11C/80/LAP/#2.011 CD11C
CD3-specific antibody-induced immune tolerance and suppression of autoimmune encephalomyelitis involves TGF-β production through phagocytes digesting apoptotic T cells Sylvain Perruche 1,3, Pin Zhang 1,
More informationSupplementary Table 1 Clinicopathological characteristics of 35 patients with CRCs
Supplementary Table Clinicopathological characteristics of 35 patients with CRCs Characteristics Type-A CRC Type-B CRC P value Sex Male / Female 9 / / 8.5 Age (years) Median (range) 6. (9 86) 6.5 (9 76).95
More informationCD90 + Human Dermal Stromal Cells Are Potent Inducers of FoxP3 + Regulatory T Cells
CD90 + Human Dermal Stromal Cells Are Potent Inducers of FoxP3 + Regulatory T Cells Karin Pfisterer, Karoline M Lipnik, Erhard Hofer and Adelheid Elbe-Bürger Journal of Investigative Dermatology (2015)
More informationVISTA, a novel immune checkpoint protein ligand that suppresses anti-tumor tumor T cell responses. Li Wang. Dartmouth Medical School
VISTA, a novel immune checkpoint protein ligand that suppresses anti-tumor tumor T cell responses Li Wang Dartmouth Medical School The B7 Immunoglobulin Super-Family immune regulators APC T cell Co-stimulatory:
More informationCellular biomarkers of T lymphocyte func6on. Michael Be9s University of Pennsylvania Department of Microbiology
Cellular biomarkers of T lymphocyte func6on Michael Be9s University of Pennsylvania Department of Microbiology What T cell response parameters could be important for an effec6ve T cell based product? Specificity
More informationNKTR-255: Accessing IL-15 Therapeutic Potential through Robust and Sustained Engagement of Innate and Adaptive Immunity
NKTR-255: Accessing IL-15 Therapeutic Potential through Robust and Sustained Engagement of Innate and Adaptive Immunity Peiwen Kuo Scientist, Research Biology Nektar Therapeutics August 31 st, 2018 Emerging
More informationThe isbtc/sitc primer on tumor immunology and biological therapy of cancer: a summary of the 2010 program. Balwit et al.
The isbtc/sitc primer on tumor immunology and biological therapy of cancer: a summary of the 2010 program Balwit et al. Balwit et al. Journal of Translational Medicine 2011, 9:18 (31 January 2011) REVIEW
More informationRegulatory T cell phenotype and function 4 years after GAD alum treatment in children with type 1 diabetes
bs_bs_banner Clinical and Experimental Immunology ORIGINAL ARTICLE doi:1.1111/cei.1278 Regulatory T cell phenotype and function 4 years after GAD alum treatment in children with type 1 diabetes M. Pihl,*
More informationand follicular helper T cells is Egr2-dependent. (a) Diagrammatic representation of the
Supplementary Figure 1. LAG3 + Treg-mediated regulation of germinal center B cells and follicular helper T cells is Egr2-dependent. (a) Diagrammatic representation of the experimental protocol for the
More informationSupplemental Figure 1. Signature gene expression in in vitro differentiated Th0, Th1, Th2, Th17 and Treg cells. (A) Naïve CD4 + T cells were cultured
Supplemental Figure 1. Signature gene expression in in vitro differentiated Th0, Th1, Th2, Th17 and Treg cells. (A) Naïve CD4 + T cells were cultured under Th0, Th1, Th2, Th17, and Treg conditions. mrna
More informationRegulation of anti-tumor immunity through migration of immune cell subsets within the tumor microenvironment Thomas F. Gajewski, M.D., Ph.D.
Regulation of anti-tumor immunity through migration of immune cell subsets within the tumor microenvironment Thomas F. Gajewski, M.D., Ph.D. Professor, Departments of Pathology and Medicine Program Leader,
More informationRapamycin reduced inhibition of V 1 T cells towards V 4 T cells through down-regulating IL-4
Rapamycin reduced inhibition of V 1 T cells towards V 4 T cells through down-regulating IL-4 Wanjun Huang Biomedical Translational Research Institute, Jinan University, Guangzhou 510632, China. Abstract
More information